Is telehealth allowed to prescribe Mounjaro?

Understanding Telehealth Prescriptions for Weight Loss Medications

The landscape of obesity treatment has transformed dramatically with the emergence of GLP-1 medications like Wegovy, Ozempic, and Mounjaro. As these highly effective weight loss options gain popularity, many patients wonder whether they can access them through convenient telehealth services rather than traditional in-person doctor visits.

The short answer? Yes, in most cases, you can legally obtain GLP-1 weight loss medications through telehealth in the United States. However, the specific requirements vary by state, and understanding these differences is crucial for anyone considering this treatment path.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

How Telehealth Prescribing Works for GLP-1 Medications

GLP-1 agonists (glucagon-like peptide-1) are a class of medications that were initially developed to treat type 2 diabetes but have shown remarkable effectiveness for weight management. These medications work by mimicking hormones that regulate appetite and blood sugar, helping patients feel fuller longer and potentially lose significant weight.

Unlike many other weight loss medications, GLP-1s like Wegovy (semaglutide) and Mounjaro/Zepbound (tirzepatide) are not controlled substances. This distinction is critical because:

• Non-controlled medications aren’t subject to the Ryan Haight Act’s in-person examination requirements
• Telehealth providers can legally prescribe them without a prior face-to-face visit under federal law
• They can be prescribed electronically to pharmacies nationwide

Dr. Sarah Thompson, a telehealth provider at Klarity Health, explains: ‘Since GLP-1 medications aren’t controlled substances, they fall under different prescribing rules than medications like phentermine or Adderall. This gives us more flexibility to help patients access these effective treatments remotely while still maintaining appropriate medical oversight.’

State-by-State Regulations: What You Need to Know

While federal law permits telehealth prescribing of GLP-1s, individual states have their own regulations that can affect your ability to get these medications online. Here’s what varies by location:

States with Minimal Restrictions

In several states, the telehealth process for GLP-1s is straightforward:

• California: No in-person exam required; telehealth evaluation is sufficient
• New York: Allows full telehealth prescribing with no special restrictions
• Washington: Pioneering telehealth state with no in-person requirements for GLP-1s
• Illinois: Permanent telehealth laws allow remote prescribing without in-person visits

States with Moderate Restrictions

Some states require additional steps but still permit telehealth prescribing:

• Florida: Allows telehealth prescribing but mandates follow-up visits at least once every three months and has specific BMI requirements
• Virginia: Requires comprehensive initial evaluation including lab work and a personalized diet/exercise plan
• Pennsylvania: Permits telehealth prescribing but requires provider-patient relationship establishment

States with Stricter Requirements

A few states maintain more significant barriers:

• Arkansas: Requires an initial in-person examination before telehealth prescribing
• Georgia: Mandates an in-person exam prior to telehealth treatment for weight management
• South Carolina: Initial in-person examination required before ongoing telehealth care

‘Even in states with stricter rules, telehealth can still be part of your weight management journey,’ notes Maria Gonzalez, NP, at Klarity Health. ‘It might involve an initial in-person visit followed by convenient telehealth follow-ups for monitoring and prescription adjustments.’

Who Can Prescribe GLP-1s via Telehealth?

The qualifications of providers who can prescribe GLP-1 medications through telehealth also vary by state:

• Physicians (MDs and DOs) can prescribe in all states (when licensed in the patient’s state)
• Nurse Practitioners (NPs) have full independent prescribing authority in about half of U.S. states (including California, New York, and Washington)
• Physician Assistants (PAs) typically require some level of physician collaboration but can prescribe in all states under appropriate supervision

In states with ‘collaborative practice’ requirements, NPs and PAs must have formal agreements with physicians to prescribe medications. For example, Texas requires NPs to have a delegating physician relationship, while Florida has certain limitations on NP autonomy outside primary care.

What to Expect During Telehealth Weight Loss Consultation

A legitimate telehealth consultation for GLP-1 weight loss medications should include:

1. Comprehensive Screening

• Detailed medical history
• Current height, weight, and BMI calculation (typically must be ≥30, or ≥27 with weight-related conditions)
• Medication review and allergy screening
• Discussion of previous weight loss attempts

2. Evaluation of Medical Appropriateness

• Assessment for contraindications (pregnancy, personal/family history of medullary thyroid carcinoma, etc.)
• Review of current health conditions
• Discussion of potential interactions with existing medications

3. Treatment Plan Development

• Information about how GLP-1 medications work
• Dosing schedule (typically starting with a lower dose and gradually increasing)
• Complementary lifestyle modifications (diet and exercise recommendations)
• Side effect management strategies

4. Follow-up Schedule

• Initial follow-up within the first month
• Regular check-ins every 2-3 months (or as required by state law)
• Weight progress tracking
• Potential laboratory monitoring

At Klarity Health, providers follow this comprehensive approach while maintaining the convenience telehealth offers. ‘We ensure the same standard of care you’d receive in person,’ explains Dr. Thompson. ‘The difference is you can access it from your home, saving time and removing barriers to consistent care.’

Avoiding Red Flags: Ensuring Safe Telehealth Prescribing

The popularity of GLP-1s has unfortunately led to some questionable telehealth practices. Watch for these warning signs:

• Providers who guarantee prescriptions without thorough medical evaluations
• Services offering ‘compounded’ versions of semaglutide (FDA banned most compounding in 2025)
• Websites that don’t verify your identity or request minimal medical information
• Lack of follow-up appointments or monitoring
• Absence of provider credentials or state licensing information
• Programs that don’t discuss potential risks or side effects
• Requests to pay for medication directly through the telehealth service

Reputable telehealth providers like Klarity Health will always conduct proper medical screenings, maintain transparency about their providers’ credentials, and send prescriptions to licensed pharmacies rather than shipping medications directly to patients.

Insurance Coverage and Cost Considerations

GLP-1 medications can be expensive, with brand-name products like Wegovy potentially costing over $1,300 monthly without insurance. When using telehealth services:

• Insurance coverage: Many telehealth providers accept insurance for consultations, but coverage for the medications themselves varies widely among insurance plans
• Prior authorization: Your telehealth provider can help submit documentation to your insurance showing the medical necessity of treatment
• Manufacturer savings programs: Available for eligible patients with commercial insurance
• Cash pay options: Most telehealth providers offer transparent pricing for those without insurance coverage

‘At Klarity Health, we accept both insurance and offer clear cash pay pricing,’ says Jessica Williams, Patient Care Coordinator. ‘We believe in removing financial barriers to effective treatment whenever possible.’

The Future of Telehealth Weight Management

Telehealth prescribing of GLP-1s appears here to stay, with regulations generally moving toward greater accessibility while maintaining appropriate safeguards:

• Current DEA telehealth flexibilities for controlled substances are extended through December 31, 2025
• State medical boards continue to update telehealth rules to reflect modern practice
• More states are expanding nurse practitioner autonomy, potentially increasing provider availability
• Regulatory focus is shifting toward ensuring quality care rather than restricting telehealth access

For patients with obesity, telehealth represents a practical solution to ongoing care needs, reducing barriers like transportation challenges and time constraints that might otherwise prevent consistent treatment.

Taking the Next Step

If you’re considering GLP-1 medications for weight management, telehealth offers a legitimate, convenient path to treatment for many patients. However, success depends on choosing a reputable provider who adheres to medical standards and state regulations.

When evaluating telehealth options:

1. Confirm the service works with licensed providers in your state
2. Expect a thorough medical evaluation
3. Understand the follow-up protocol
4. Verify transparent pricing
5. Ensure the service has a clear process for medication adjustments if needed

Weight management is a journey that requires ongoing support. The right telehealth provider can be your partner in sustainable weight loss, combining effective medication with lifestyle guidance and consistent monitoring—all from the comfort of your home.

Ready to

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid